Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

The effect of a transitional pharmaceutical care program on the occurrence of ADEs after discharge from hospital in patients with polypharmacy.

Uitvlugt EB, Heer SE, van den Bemt BJF, et al. The effect of a transitional pharmaceutical care program on the occurrence of ADEs after discharge from hospital in patients with polypharmacy. Res Soc Admin Pharm. 2022;18(4):2651-2658. doi:10.1016/j.sapharm.2021.05.009.

Save
Print
April 27, 2022
Uitvlugt EB, Heer SE, van den Bemt BJF, et al. Res Soc Admin Pharm. 2022;18(4):2651-2658.
View more articles from the same authors.

Pharmacists play a critical role in medication safety during transitions of care. This multi-center study found that a transitional pharmacy care program (including teach-back, pharmacy discharge letter, home visit by community pharmacist, and medication reconciliation by both the community and hospital pharmacist) did not decrease the proportion of patients with adverse drug events (ADE) after hospital discharge. The authors discuss several possible explanations as to why the intervention did not impact ADEs and suggest that a process evaluation is needed to explore ways in which a transitional pharmacy care program could reduce ADEs.

Save
Print
Cite
Citation

Uitvlugt EB, Heer SE, van den Bemt BJF, et al. The effect of a transitional pharmaceutical care program on the occurrence of ADEs after discharge from hospital in patients with polypharmacy. Res Soc Admin Pharm. 2022;18(4):2651-2658. doi:10.1016/j.sapharm.2021.05.009.

Related Resources From the Same Author(s)